The ability to recognise women who are at-risk of preterm labour (PTL) is often difficult. Over 50% of women who are identified with factors associated with an increased risk of preterm birth will ultimately deliver at term. The cervicovaginal fluid (CVF) comprises a range of proteins secreted by gestational tissues, making it an ideal candidate for the screening of differentially expressed proteins associated with PTL. CVF samples were collected from at-risk asymptomatic women. Two-dimensional gel electrophoresis techniques were used to examine the CVF proteome of women who spontaneously delivered preterm 11-22 days later compared with gestation-matched women who delivered at term. Five candidate biomarkers were selected for further validation in a larger independent cohort of asymptomatic women. Thioredoxin (TXN) and interleukin 1 receptor antagonist (IL1RN) concentrations in the CVF were found to be significantly reduced up to 90 days prior to spontaneous PTL compared with women who subsequently delivered at term. TXN was able to predict spontaneous PTL within 28 days after sampling with a high positive predictive value (PPV) and negative predictive value (NPV) of 75.0% and 96.4% respectively. IL1RN also showed comparable PPV and NPV of 72.7% and 95.7% respectively. The discovery of these differentially expressed proteins may assist in the development of a new predictive bedside test in identifying asymptomatic women who have an increased risk of spontaneous PTL.
Introduction
Preterm birth accounts for w5-18% of all live births worldwide (Blencowe et al. 2012) and is a significant contributor to infant mortality and long-term morbidity, including an increased risk of severe impaired neurodevelopment and respiratory complications (Norwitz & Robinson 2001 , Johnson et al. 2009 , Stephens & Vohr 2009 ). The aetiology of spontaneous preterm labour (PTL) is thought to be a complex, multifactorial process not limited to precipitating factors including haemorrhage, cervical dysfunction, idiopathic contractions, infection, malnutrition, multifetal pregnancy and spontaneous preterm rupture of the fetal membranes. Furthermore, of women who are considered at high risk of preterm birth (e.g. previous preterm birth and twin gestation), !50% will deliver prematurely (Adams et al. 2000) . This emphasises the difficulty in recognising women that will deliver preterm.
There are currently two diagnostic tests routinely used to identify pregnant women who are at an increased risk of spontaneous PTL. The efficacy of these commercially available tests relies on the abnormal presence of either fetal fibronectin (fFN) or phosphorylated insulin-like growth factor-binding protein 1 (phIGFBP1) in the cervicovaginal fluid (CVF). The detection of these proteins in the CVF indicates a disruption at the choriodecidual interface that in turn could lead to subsequent (preterm) birth (Malak et al. 1996 , Elizur et al. 2005 . The fFN test in particular has limited utility to predict PTL due to its low positive predictive value (PPV) as well as false-positive results caused by recent unprotected sexual intercourse. In the asymptomatic pregnant population to date, there is no single biomarker that provides a high PPV for women at risk of preterm birth.
As labour approaches, the cervix and overlying fetal membranes undergo extensive tissue remodelling and inflammation. At term, biochemical evidence of these changes is apparent in the CVF , 2010a , 2010b , 2010c . We hypothesise that these dynamic changes represent a common final pathway leading to spontaneous labour whether this occurs at term or preterm, irrespective of underlying risk factor(s). Therefore, the aim of this longitudinal observational study was to i) characterise the CVF proteome of at-risk asymptomatic pregnant women who subsequently experienced spontaneous PTL using discovery-based methods (two-dimensional difference in-gel electrophoresis (2D-DIGE), two-dimensional PAGE (2D-PAGE) and mass spectrometry), ii) perform biomarker validation in an independent cohort of women who spontaneously delivered preterm, iii) further investigate specific biomarkers of interest and iv) assess the utility of these biomarkers to predict spontaneous PTL.
Subjects and methods

Subject recruitment
The collection of CVF from pregnant women was approved by the Mercy Health Research Ethics Committee (R06/56). Healthy, pregnant women attending Antenatal Clinic at the Mercy Hospital for Women (Heidelberg, Australia), were recruited by a research midwife. All participants involved in this longitudinal observational study provided informed, written consent. Each woman was assessed for a range of clinical risk factors associated with an increased likelihood of spontaneous preterm birth. Women with one or more of the following risk factors were recruited: a history of spontaneous preterm delivery or preterm premature rupture of the fetal membranes (preterm PROM), a shortened cervix (!20 mm based on ultrasonographic diagnosis), a history of cervical cone biopsy, uterine anomaly and twin pregnancy. Exclusion criteria for recruitment were obstetric complications such as hypertension and diabetes mellitus, multifetal pregnancy of triplet or higher order gestation, known fetal anomaly and symptoms/ signs of PTL. At the time of recruitment, participants were asked whether they had had unprotected sexual intercourse in the preceding 48 h, experienced vaginal bleeding in the preceding 24 h, or had a transvaginal ultrasound or digital vaginal examination performed in the 6 h prior to CVF sample collection. Participants were also questioned on whether they were taking any medications (oral and/or vaginal).
Study design
All recruited participants had CVF samples collected every 4 weeks, beginning at 20-24 weeks of gestation and finished once 35 weeks of gestation was reached or spontaneous preterm delivery had occurred. CVF samples used for analysis were retrospectively selected based on pregnancy outcomes. Sample exclusion criteria were spontaneous PTL due to chorioamnionitis, a diagnosis of bacterial vaginosis, and digital vaginal examination or transvaginal ultrasound 6 h prior to CVF collection. No in-labour CVF samples were included in this study. None of the CVF swabs were macroscopically contaminated with blood. Once birthing outcome was verified, the following investigations were performed:
Discovery cohort
Participants in the discovery cohort were stratified post hoc into two groups. Samples obtained within 11-22 days before spontaneous PTL onset (nZ5 singleton pregnancies) were compared with a control group consisting of gestation-matched samples obtained from at-risk women who subsequently experienced a spontaneous term delivery (nZ10 singleton pregnancies).
Validation cohort
ELISA validation of identified biomarkers was performed in an independent cohort of women. Participants that subsequently experienced spontaneous PTL 2-22 days later (nZ13-24 samples) were compared with gestation-matched control samples obtained from at-risk women who subsequently experienced a spontaneous term delivery (nZ55-86 samples). CVF samples collected from both singleton and twin gestation pregnancies were included in the validation cohort. 
S Liong and others
Further investigation of biomarkers of interest ELISA validation of two specific biomarkers was performed on independent samples derived from our CVF tissue bank. These CVF samples were collected from women at 20-35 weeks of gestation following the same recruitment criteria described earlier (nZ165 for thioredoxin (TXN) and nZ225 for interleukin 1 receptor antagonist (IL1RN)) and stratified based on days before spontaneous labour (term, nZ97-150 vs preterm, nZ68-75) .
Twin gestation pregnancies were included in this study.
Predictive modelling
Participants that subsequently experienced either a spontaneous preterm (nZ55 samples) or term labour (nZ94 samples) were included in the predictive model. Twin gestation pregnancies were included in the modelling.
Sample collection
All CVF swabs were performed prior to the rupture of the fetal membranes to avoid amniotic fluid contamination. CVF was collected from pregnant women during a routine speculum examination as described previously (Di Quinzio et al. 2007) . A dual-tipped swab was placed in the posterior fornix of the vagina for 30 s. The swab was then placed into 1 ml chilled CVF extraction buffer (50 mM HEPES, 150 mM NaCl, 0.1% SDS, 1 mM EDTA and 1 mM Pefabloc SC 4-(2-aminoethyl) benzene sulphonyl fluoride (Roche Diagnostics GmbH)). Samples were processed immediately according to previously published methods and extracted CVF was stored at K80 8C (Di Quinzio et al. 2007 ).
Vaginal microbiology
At the time of CVF collection, a high vaginal swab was obtained for microbiological culture as per standard clinical laboratory methods.
Two-dimensional difference in-gel electrophoresis
Equivalent protein concentrations of individual samples were pooled accordingly into the appropriate groups (discovery cohort: preterm birth vs gestation-matched term controls). Pooled samples were precipitated using the 2D Clean-Up Kit (GE Healthcare, Piscataway, NJ, USA) and resolubilised in rehydration buffer (7 M urea, 2 M thiourea, 4% (w/v) CHAPS and 30 mM Tris). In each group, 25 mg protein were labelled with 200 pmol of either Cy3 or Cy5 dye (CyDye DIGE Fluor minimal dye, GE Healthcare). To normalise protein abundance between groups, an internal standard (labelled with Cy2 dye) was used. Dye swapping was also used to account for labelling bias. Twenty-five micrograms of Cy2-, Cy3-and Cy5-labelled protein from each group were combined and loaded onto 11 cm immobilised pH gradient strips (pH 4-7 linear gradient IPG Ready Strip; Bio-Rad Laboratories, Hercules, CA, USA) and subjected to first-dimension separation at 34 000 Vh. IPG strips were then equilibrated first in dithiothreitol and secondly in iodoacetamide buffers. Criterion 8-16% Tris-HCl polyacrylamide gradient gels (Bio-Rad Laboratories) were used for the second-dimension protein separation. Gels were scanned at 100 nm resolution in a Typhoon 9400 scanner (GE Healthcare) using the following lasers: 580 BP 30 (Cy3; PMT voltage: 490 V), 520 BP 40 (Cy2; 480 V) and 670 BP 30 (Cy5; 670 V).
Mass spectrometry
Gels were fixed in 10% acetone/25% isopropanol solution and counter-stained with a Coomassie G-250-based dye (PageBlue; Fermentas, Burlington, ON, Canada). Protein spots of interest were manually excised, reduced, alkylated and digested with trypsin overnight as described previously . LC-ESI-MS/MS was performed using an Agilent 1100 Series HPLC coupled to an Agilent LC/MSD Trap XCT Plus Mass Spectrometer fitter with an HPLC Chip cube (Agilent, Palo Alto, CA, USA). Mass spectrometer settings can be found in a previously published protocol . The peptide sequences from the MS/MS spectra obtained were identified by correlation with the peptide sequences from proteins present in the Swiss-Prot database (version 2011_06) using the MASCOT search algorithm (Matrix Science Inc, Boston, MA, USA). Typical MASCOT search parameters that were used are as follows: peptide mass tolerance, G1.2 Da; fragment mass tolerance, G0.6 Da; missed cleavages, 1; enzyme, trypsin; fixed modifications, cysteine modified by carbamidomethyl; variable modifications, oxidation (M) and taxonomy, Homo sapiens.
Two-dimensional PAGE
Confirmation of protein fold changes was performed using 2D-PAGE analysis of individual samples. Precipitation of the CVF proteins using the trichloroacetic acid precipitation method (Di Quinzio et al. 2007 ) was performed on each sample. Fifteen micrograms of protein were subjected to firstand second-dimension separation in a similar method as described in the aforementioned 2D-DIGE protocol. Gels were fixed and stained using SYPRO Ruby (Bio-Rad Laboratories) according to a previously published protocol (Di Quinzio et al. 2007 ). Gels were scanned at 100 nm resolution in a FX imager (Bio-Rad Laboratories). A match set of all 15 gels was produced and spots of interest in the initial 2D-DIGE analysis were further investigated using PD Quest v7.3.1 Software (Bio-Rad Laboratories).
Spot volumes determined by PD Quest were used to calculate fold changes of matched spots. Matched spots that showed significant differences in volume by PD Quest were confirmed using the Mann-Whitney U test (Statistical Package for Social Sciences (SPSS) v20 Software). P!0.05 was determined as being statistically significant.
ELISA
Commercially available ELISA kits were used to quantify the concentrations of albumin (ALB; Cayman Chemical Company, Ann Arbor, MN, USA), Cu, Zn-superoxide dismutase (SOD1; Benders Medsystem GmbH, Vienna, Austria), IL1RN (DuoSet kits, R&D Systems, Minneapolis, MN, USA) and TXN (AbFRONTIER, Seoul, South Korea) in the CVF. Quantification of cystatin A (CSTA) was performed using paired antibodies from R&D Systems (mouse anti-human CSTA monoclonal IgG2A clone 224705 and goat anti-human CSTA biotinylated polyclonal IgG antibodies) following an in-house ELISA protocol, as described previously (Heng et al. 2011) .
The ALB ELISA was reported by the manufacturer to have a sensitivity of 23.4 pg/ml and the inter-and intra-assay coefficients of variation (CV) reported as 5.5-14.4 and 8.2-17.4% respectively. For SOD1, the values reported by the manufacturer were 37.6 pg/ml, 4.5 and 5.1% respectively. The IL1RN DuoSet ELISA kit sensitivity and inter-and intra-assay CV were determined as 3.6 pg/ml, 6 and 5.6% respectively. For TXN, the values were 0.39 ng/ml, 10 and 7% respectively. The sensitivity and CV values for the in-house CSTA ELISA were 58.1 pg/ml, 12.0 and 5.0% respectively.
Protein concentrations as determined by ELISA were normalised against the total protein content of each CVF sample and are expressed as per milligram of protein. The total protein concentration was determined using the bicinchoninic acid protein assay (Pierce, Rockford, IL, USA) using the manufacturer's instructions.
Statistical analyses
Statistical analyses were performed on protein-corrected data using the SPSS Software (version 20). Homogeneity of variance of the data for each of the five biomarkers was performed and found to be not normally distributed (P!0.05, KolmogorovSmirnov test). Data were normalised by log transformation. Student's t-test or Mann-Whitney U test was performed where appropriate. Two-way ANOVA with post hoc Tukey's Honestly Significant Difference (HSD) was used to compare multiple groups. Statistical significance was assumed when P!0.05. Receiver operating characteristic (ROC) curves were constructed and binary logistic regression was performed to determine the utility of the validated biomarkers to predict PTL within 28 days.
Results
The demographic and clinical data of participants in the discovery cohort are described in Table 1 . Common genital microflora was detected in all 15 women. No participant had bacterial vaginosis. Three women had Ureaplasma urealyticum isolated on microbiological culture and two of these women (one in each group) subsequently received a course of oral erythromycin.
CVF proteome map of impending preterm birth CVF samples were analysed by 2D-DIGE with proteins separated over the 4-7 pH range (Fig. 1A) . A total of 563 spots were visualised and quantified by Progenesis SameSpots analysis software (Nonlinear Dynamics Ltd, Newcastle upon Tyne, UK). Spots that displayed a 1.2-fold or greater fold difference in volume were further analysed. Ninety-three spots were down-regulated and 103 spots were up-regulated in asymptomatic women who spontaneously delivered preterm (within 11-22 days) compared with gestation-matched women who subsequently delivered at term.
Protein characterisation
Spots that were visible to the naked eye were manually excised and subjected to mass spectrometry. Only 22 spots were confidently identified, which represented 17 unique proteins (Table 2 ). Identical proteins characterised from different spots reflect the existence of multiple isoforms that differ in MW and/or pI. The location of successfully identified spots on the CVF proteome map is displayed in Fig. 1B . The peptide sequences of the identified proteins are described in Supplementary Table 1 .
The spot density of ten different proteins was reduced in women with spontaneous preterm birth compared with gestation-matched control subjects: apolipoprotein A1 (spot 232), CSTA dimer (spot 571), SOD1 (spot 585), fatty acid-binding protein 5 (FABP5; spots 310 and 306), g-glutamyl cyclotransferase (GGCT; spot 250), IL1RN (; spot 264), S100 calcium-binding protein A7 (S100A7; spot 551), squamous cell carcinoma antigen 1 (SER-PINB3; spot 118), TXN (spot 318) and transaldolase (TALDO1; spot 123). Conversely, ALB (spots 156 and 157), glutathione S-transferase-p (GSTP1; spot 233), placental thrombin inhibitor (SERPINB6; spot 119), squamous cell carcinoma antigen 2 (SERPINB4, spot 11-22 days before PTL Gestation-matched term controls Figure 2 Raw images of 2D-PAGE gels of individual CVF samples collected from asymptomatic women in the discovery cohort who experienced PTL within 11-22 days of sample collection and gestationmatched women who delivered at term. Table 2) .
Confirmation of fold changes using 2D-PAGE
To confirm the fold changes of specific proteins of interest between the two pooled clinical groups, each sample was individually subjected to 2D-PAGE analysis (Fig. 2) . Between all gels, spot detection ranged from 226 to 402 spots. A single 'master gel' was created from the 15 gel match set and comprised of 30 common spots. Each spot was assigned an arbitrary number generated by the PD Quest Software for statistical analysis and spot characterisation. Differentially expressed spots (based on spot volume) that had been confidently identified by mass spectrometry were matched in all 2D-PAGE gels. A total of eight identified spots showed significant changes in the mean spot volumes (GS.D.) 11-22 days prior to spontaneous PTL (Table 3) . In contrast, two proteins were significantly increased (ranging from 2.5-to 3.9-fold) 11-22 days prior to spontaneous PTL: GSTP1 (PZ0.008, M-W test) and GC (spot 45, PZ0.003, M-W test). Although the 2D-DIGE analysis showed ALB to have a 2.7-fold change with PTL, the 2D-PAGE analysis could not resolve the multiple ALB isoforms, and thus fold change was unable to be confirmed. Comparison of the fold changes calculated from the pooled groups (2D-DIGE) and individual samples (2D-PAGE) was consistent between the two proteomic techniques (Table 3) .
Independent validation of selected biomarkers
A select number of differentially expressed proteins identified by 2D-DIGE were investigated further using ELISA to validate their concentrations in a larger independent cohort of women that spontaneously delivered 2-22 days before PTL. The clinical data of these women in the independent cohort are summarised in Table 4 . When comparing singleton and twin pregnancies, there was no significant difference in TXN, SOD1, IL1RN, CSTA and ALB concentrations in women with either term or PTL outcomes (Fig. 3) . TXN was 4.3-fold significantly lower in women with subsequent PTL compared with women who laboured at term (P!0.001, t-test; Fig. 4A ). In contrast, although our discovery cohort demonstrated a significant decrease in SOD1 with impending PTL, when measured in a larger cohort of women, there was no significant difference detected between women with subsequent PTL and women with term deliveries (PZ0.839, M-W test; Fig. 4B ). In agreement with the 2DE findings, IL1RN was lower in women who subsequently delivered preterm compared with term women (3.0-fold; PZ0.021, t-test; Fig. 4C ). Although the median concentration of CSTA was 1.7-fold lower in women with subsequent PTL compared with gestation-matched term women, there was no significant difference between the two groups (PZ0.397, t-test; Fig. 4D ). The ALB concentration was also measured in the CVF between women who delivered preterm compared with term controls. In the CVF of women with subsequent PTL, ALB was 2.5-fold higher than in gestation-matched term controls. This difference however failed to reach statistical significance (PZ0.729, t-test; Fig. 4E ) in the independent cohort.
Further investigation of TXN and IL1RN
Using a larger cohort of women over an extended time frame from labour, TXN and IL1RN were further investigated. Both biomarkers displayed an overall reduced concentration up to 132 days before spontaneous PTL onset. Statistical differences were evident between 31 and 90 days from labour (P!0.05; Fig. 5 ).
Prediction of PTL
A total of 149 CVF samples collected from 61 women (Table 5) were screened for both TXN and IL1RN. ROC curves were generated to visualise each biomarker's overall efficacy to predict spontaneous preterm birth within 28 days of labour onset (Fig. 6 ). The area under the curve (AUC) for each biomarker is shown in Table 6 : 0.963 for TXN and 0.959 for IL1RN (P!0.001). TXN was able to predict spontaneous PTL with 64.3% sensitivity, 97.8% specificity, 75.0% PPV and 96.4% negative predictive value (NPV) using a probability cut-off value of 0.4. Based on a probability cut-off value of 0.4, IL1RN was able to identify women with subsequent PTL with 57.1% sensitivity, 97.8% specificity, 72.7% PPV and 95.7% NPV. Logistic binary regression was used to generate a combined biomarker model using samples that had been screened for both TXN and IL1RN. This combined model resulted in a AUC of 0.973 (P!0.001) and, based on a probability cut-off value of 0.4, was able to predict spontaneous PTL with 64.3% sensitivity, 97.8% specificity, 75.0% PPV and 96.4% NPV.
Discussion
There have been a limited number of proteomic studies endeavouring to discover differentially expressed proteins in the CVF in association with preterm birth (Pereira et al. 2007 , Shah et al. 2009 ). As we continue to elucidate the role of these biochemical markers in preterm birth, there is yet to be developed a predictive test superior to the current 'gold standards' of fFN and the IGFBP1. Unfortunately, introduction of these tests has had little impact on global preterm birth rates.
Utilising 2D-electrophoretic proteomic analysis of CVF from asymptomatic women who ultimately spontaneously delivered preterm, we have identified a number of proteins associated with impending preterm birth. Following the discovery phase of this project, we chose to validate five proteins of interest in association with subsequent PTL largely based on availability of suitable ELISA reagents. Validation of ALB in the CVF was performed on the basis of a relatively high fold change observed in 2D-DIGE even though this could not be statistically confirmed due to technical limitations of 2D-PAGE. Although GC also displayed a significant change in association with spontaneous preterm birth, this is the subject of a separate manuscript (Liong et al., manuscript under review) . Using an independent cohort of women who subsequently experienced spontaneous PTL, two CVF biomarkers of significance (TXN and IL1RN) may show future promise as part of a multiple marker test for the prediction of spontaneous PTL.
CVF proteomic analysis of women with subsequent PTL revealed two antioxidant proteins that were significantly altered when compared with the gestation-matched term-delivered women. TXN is reported to inhibit cellular apoptosis, protect against ROS-induced tissue damage (Saitoh et al. 1998) and may indirectly affect pro-inflammatory cytokines, prostaglandins and COX-2 production through its regulatory influence on the transcription factors NFkB and AP-1 (Hirota et al. 2000) . Our CVF proteomic and validation studies on the temporal concentration of TXN in the term labour model reflect similar decreasing trends observed in our current study on at-risk asymptomatic women with impending spontaneous PTL (Di , Heng et al. 2010b . The second antioxidant protein, SOD1, is a scavenger of oxidative free radicals and is able to convert superoxide anions to form oxygen and hydrogen peroxide. The proteolytic activity of matrix metalloproteinase 9 is increased in fetal membranes by the presence of superoxide anions and is reversed by the addition of SOD (Buhimschi et al. 2000) . SOD1 may promote uterine quiescence by prolonging the half-life of nitric oxide, a free radical capable of inducing myometrial tocolysis (Telfer et al. 1997) . The reduced concentration of SOD1 in women who experienced spontaneous preterm birth was not confirmed in the validation cohort and speculates that the assay could not differentiate between two isoforms of SODs that both contain Cu and Zn ions (intracellular SOD1 and extracellular EC-SOD; Fridovich 1995 , Zelko et al. 2002 .
The members of the IL1 family have been extensively characterised in their association with human parturition. IL1b in particular is reported to have the capacity to induce the synthesis of prostaglandins in human amnion tissue (Romero et al. 1989) . Furthermore, the amniotic fluid collected from women in labour compared with that collected from those not in labour at term was associated with increased IL1b (Romero et al. 1990 ). The pro-inflammatory effects of IL1 are regulated by IL1RN, which is able to dampen the IL1a/b-induced inflammatory signals through the competitive binding of the IL1 cell surface receptor. In the current study, women who subsequently delivered preterm had significantly lower IL1RN than gestation-matched women who delivered at term. The dysregulation of the IL1 system in women with subsequent preterm birth outcomes is consistent with the hypothesis that labour is an inflammatory process. IL1RN is also decreased in the CVF with approaching spontaneous term labour .
CSTA is a cysteine protease inhibitor inhibiting the biological actions of cathepsins B, H and L. This study showed that the dimer of CSTA was significantly decreased in association with spontaneous PTL. Other proteomic analyses of the CVF collected from pregnant women have also reported decreased concentration of CSTA with term labour , Heng et al. 2011 , PTL (Pereira et al. 2007 ) and preterm PROM . Unfortunately, although our validation work in this study showed an overall decrease in CSTA concentration before spontaneous PTL compared with term controls, this difference failed to reach statistical significance. This discrepancy between our 2DE and ELISA results may be caused by the CSTA ELISA being unable to discriminate between the monomeric and dimeric forms of CSTA. This limitation of the ELISA as a result may have failed to detect the relative concentration changes between the two forms.
ALB is an abundant plasma protein involved in the regulation of capillary osmotic pressure. It can also function as a transporter protein for fatty acids and act as a carrier protein for progesterone as well as possessing antioxidant properties (Kragh-Hansen et al. 1990 , Quinlan et al. 2004 , Fanali et al. 2012 . Our 2D-DIGE analysis displayed a 2.7-fold increase in ALB in the CVF of women with subsequent PTL. Although ALB was not significantly different in our validation cohort, this may be a result of a small sample size in the PTL group. 1 -Specificity Figure 6 The efficacy of candidate CVF biomarkers to predict spontaneous PTL in at-risk asymptomatic women within 28 days after sampling is illustrated using receiver operating characteristic (ROC) curves. TXN (solid line) and IL1RN (dashed line) as single biomarkers and as a combined multi-biomarker model (dotted line) had comparable efficacy in predicting PTL. Based on a probability cut-off value of 0.4. Proteomic analysis of the CVF of women with subsequent preterm PROM also reported significantly increased ALB compared with gestation-matched women who delivered at term and we hypothesise that an increase in ALB concentration in the CVF may indirectly reflect the up-regulated pro-inflammatory processes that are associated with spontaneous membrane rupture and labour. The accurate prediction of spontaneous preterm birth remains a major challenge in part due to the multifactorial aetiology underlying the potential trigger(s) of labour. In a study of labour at term and preterm gestations, excluding evidence of infection, Törnblom et al. (2005) found no difference in the cervical expression of inflammatory cytokines based on gestational age, suggesting that the cervical ripening was a similar process at term and preterm gestations. The CVF proteomic findings reported in this study of women who delivered preterm is supported by similar temporal changes in TXN, SOD1, IL1RN, CSTA and GC concentrations in association with spontaneous term labour , 2010b , 2010c . It is therefore feasible that the proteomic patterns of change presented in this study may represent part of the common final biochemical pathway of labour, irrespective of gestation or the underlying trigger leading to labour and delivery. It is interesting that women who subsequently delivered preterm were found to have lower 'baseline' concentrations of TXN and IL1RN long before the onset of labour. We speculate that this may influence the cumulative threshold of multiple biomarkers or triggers required for spontaneous labour onset.
This study indicates that TXN and IL1RN may be promising biomarkers for the prediction of spontaneous preterm birth in asymptomatic women. The current 'gold standard' tests for the prediction of PTL (fFN and phIGFBP1) are applicable up to a 14-day window at best. As individual biomarkers, TXN provided a PPV of 75.0% and a NPV of 96.4%, while IL1RN provided a PPV of 72.7% and a NPV of 95.7% in predicting spontaneous preterm birth up to 28 days before onset. The combination of the two biomarkers did not improve the overall predictive efficacy. It should be emphasised that most women provided multiple CVF samples in the construction of the predictive model and the subject was included as a categorical variable.
In conclusion, the characterisation of the CVF proteome of asymptomatic women with impending spontaneous PTL has revealed a number of differentially expressed proteins involved in inflammation, proteinase inhibition and oxidative stress that may contribute to cervical ripening and myometrial activation and therefore initiate parturition. Many of these proteins have been previously characterised in the term labour setting, suggesting a common biochemical pathway involved in term and PTL. A comprehensive diagnostic trial of these biomarkers in the general obstetric population is now required. The development of a multi-marker predictive test that may include other indices such as cervical length and fFN will be invaluable for the early intervention, appropriate management and care for preterm babies and their mothers.
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